If your email program has trouble displaying this email, view as a webpage.

Update: SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests

Today, the U.S. Food and Drug Administration (FDA) updated the SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests web page to state the emergency use authorization (EUA) for the Luminostics, Inc. Clip COVID Rapid Antigen Test has been revoked at the manufacturer’s request.

Questions?

If you have questions about this update, email COVID19DX@fda.hhs.gov.